Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Schnaiter

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 7, 2024
Gonadal and gonadosomatic mosaicism in NF1: report of two familiesMagdalena Seidl-Philipp, Nathalie Veyt, Simon Schnaiter, et al.
Clinical Epigenetics|November 28, 2024
BRCA loss of function including BRCA1 DNA-methylation, but not BRCA-unrelated homologous recombination deficiency, is associated with platinum hypersensitivity in high-grade ovarian cancerHeidelinde Fiegl, Simon Schnaiter, Daniel U Reimer, et al.
Scientific Reports|April 1, 2026
Absence of synergistic effects by CDK12/13 inhibition in combination with cisplatin or olaparib in ovarian cancer cellsFrédéric R Santer, Lea Hovdar, Florian Handle, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|September 11, 2015
Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes ResearchUwe Siebert, Beate Jahn, Ursula Rochau, et al.
Therapeutic Advances in Urology|March 17, 2025
Pembrolizumab and olaparib in a cisplatin-refractory testicular cancer patient with a high TMB: first case reportNils C H van Creij, Gerald Klinglmair, Leonhard Gruber, et al.
NPJ Precision Oncology|July 3, 2023
PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair systemKai Zimmer, Florian Kocher, Gerold Untergasser, et al.
European Journal of Medical Genetics|October 21, 2022
Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohortLinda A J Hendricks, Nicoline Hoogerbrugge, Hanka Venselaar, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 16, 2024
The heterogeneous cancer phenotype of individuals with biallelic germline pathogenic variants in CHEK2Snežana Hinić, Cezary Cybulski, Rachel S Van der Post, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 7, 2024
Gonadal and gonadosomatic mosaicism in NF1: report of two familiesMagdalena Seidl-Philipp, Nathalie Veyt, Simon Schnaiter, et al.
Clinical Epigenetics|November 28, 2024
BRCA loss of function including BRCA1 DNA-methylation, but not BRCA-unrelated homologous recombination deficiency, is associated with platinum hypersensitivity in high-grade ovarian cancerHeidelinde Fiegl, Simon Schnaiter, Daniel U Reimer, et al.
Scientific Reports|April 1, 2026
Absence of synergistic effects by CDK12/13 inhibition in combination with cisplatin or olaparib in ovarian cancer cellsFrédéric R Santer, Lea Hovdar, Florian Handle, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|September 11, 2015
Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes ResearchUwe Siebert, Beate Jahn, Ursula Rochau, et al.
Therapeutic Advances in Urology|March 17, 2025
Pembrolizumab and olaparib in a cisplatin-refractory testicular cancer patient with a high TMB: first case reportNils C H van Creij, Gerald Klinglmair, Leonhard Gruber, et al.
NPJ Precision Oncology|July 3, 2023
PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair systemKai Zimmer, Florian Kocher, Gerold Untergasser, et al.
European Journal of Medical Genetics|October 21, 2022
Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohortLinda A J Hendricks, Nicoline Hoogerbrugge, Hanka Venselaar, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 16, 2024
The heterogeneous cancer phenotype of individuals with biallelic germline pathogenic variants in CHEK2Snežana Hinić, Cezary Cybulski, Rachel S Van der Post, et al.
Pageof 2